NIH, Partners Commit $74.9M to New Phase of Alzheimer’s Program

by on

Called AMP AD 2.0, the new version of the 10-year-old program will support technologies including single-cell profiling and computational modeling to bring precision medicine to the development of new Alzheimer’s treatments, NIH said Tuesday.

Called AMP AD 2.0, the new version of the 10-year-old program will support technologies including single-cell profiling and computational modeling to bring precision medicine to the development of new Alzheimer’s treatments, NIH said Tuesday.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: